title: Self-administration of untested medical therapy for treatment of prostate cancer can lead to clinically significant adverse events.
authors.affiliation: Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA. adamico@iroc.harvard.edu
authors.forename: Anthony V
authors.initials: AV
authors.lastname: D'Amico
authors.forename: George
authors.initials: G
authors.lastname: Toupless
authors.forename: Lynn
authors.initials: L
authors.lastname: Lopes
authors.forename: Kristin J
authors.initials: KJ
authors.lastname: Valentine
authors.forename: Robert A
authors.initials: RA
authors.lastname: Cormack
authors.forename: Clare M
authors.initials: CM
authors.lastname: Tempany
authors.forename: Sanjaya
authors.initials: S
authors.lastname: Kumar
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Marks
mesh_terms: D019072:Antibiotic Prophylaxis; D004347:Drug Interactions; D006801:Humans; D008297:Male; D008875:Middle Aged; D009525:Niacin / Q000009:adverse effects* / Q000627:therapeutic use*; D011300:Preoperative Care; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011517:Prothrombin Time; D012651:Self Medication / Q000009:adverse effects*
chemical_list: D009525:Niacin